Tax trouble for OnePlus as GST probes lifetime display replacement programme: Report
OnePlus is facing a tax demand linked to its lifetime warranty programme that offers free screen replacements for smartphones affected […]
GST Recent News – 2026
Budget 2026-27: India’s oil industry seeks lower GST rates, compensation on LPG under recovery
India’s estimated $433.8 billion oil and gas industry has sought tax relief to boost the country’s domestic exploration and compensation
Budget 2026-27: Can GST simplification and better logistics revive retail consumption?
With Budget 2026 around the corner, India’s retail sector is looking to the government for measures that can lift consumption
Consumer companies flag demand recovery in Q3 aided by GST cuts, festive demand
After a few lackluster quarters, consumer staples firms are seeing a recovery in demand, led by the GST reforms, higher
Budget 2026: Is it time for capital gains clarity, and GST relief for real estate?
With Budget 2026 only a few days away, the real estate sector is watching closely for signals on taxation, affordability
GST rejig helps life insurers’ new business premium surge 40% in December
The life insurance industry recorded nearly 40 per cent year-on-year (Y-o-Y) growth in new business premiums (NBP), aided by the
Nagaland: GST Dept Arrests Mining Firm Director in Rs 53 Crore Fake Invoice Case
The Anti-Evasion Unit of the Central GST Commissionerate, Dimapur, has arrested a mining company director in connection with an alleged
At pre-Budget meet, Thangam Thennarasu flags GST losses, seeks release of pending dues
Tamil Nadu Finance Minister Thangam Thennarasu has urged the Union government to address issues such as revenue losses to the States under
Uttar Pradesh task force arrests four in Rs 100-cr GST scam; GST officer absconding
Uttar Pradesh Special Task Force has named a Central GST inspector in the Rs 100 crore GST evasion case, a
Budget 2026-27: Drugmakers seek tax sops, ITC expansion and PLI push for API & exports
As the Finance Ministry prepares the final contours of its fiscal blueprint for FY 2026–27, pharma industry experts called for